Clinical Trials Of Dengue Vaccine Candidate Indicate It Is Safe, Protects Against The Disease, And Produces Immunity In Children

CIDRAP (3/18, Van Beusekom) reports, “Phase 2 and 3 randomized, controlled clinical trials of Takeda’s tetravalent (four-strain) dengue vaccine candidate show that it is safe, produces immunity in children, and protects against the disease – regardless of...